A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

NCT03825731 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: GC022

Sponsor

Hebei Yanda Ludaopei Hospital

Collaborators

[object Object]